Ptc Therapeutics shares owned by Group One Trading
Quarter-by-quarter ownership of Ptc Therapeutics shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Ptc Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Ptc Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ptc Therapeutics by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $327k | 8.8k | 37.10 |
| 2024-06-30 | $165k | 5.4k | 30.58 |
| 2024-03-31 | $15k | 500 | 29.09 |
| 2023-09-30 | $186k | 8.3k | 22.41 |
| 2023-06-30 | $1.7M | 42k | 40.67 |
| 2023-03-31 | $1.1M | 23k | 48.44 |
| 2022-12-31 | $31k | 800 | 38.17 |
| 2022-09-30 | $35k | 700 | 50.00 |
| 2022-03-31 | $190k | 5.1k | 37.25 |
| 2021-12-31 | $0 | 100 | 0.00 |
| 2021-09-30 | $22k | 600 | 36.67 |
| 2021-06-30 | $17k | 400 | 42.50 |
| 2021-03-31 | $1.2M | 25k | 47.35 |
| 2020-12-31 | $2.4M | 39k | 61.03 |
| 2020-09-30 | $1.1M | 24k | 46.76 |
| 2020-06-30 | $4.5M | 88k | 50.74 |
| 2020-03-31 | $883k | 20k | 44.60 |
| 2019-12-31 | $6.7M | 139k | 48.03 |
| 2019-09-30 | $2.5M | 73k | 33.81 |
| 2019-06-30 | $1.1M | 25k | 45.00 |
| 2019-03-31 | $455k | 12k | 37.60 |
| 2018-12-31 | $474k | 14k | 34.35 |
| 2018-09-30 | $766k | 16k | 46.99 |
| 2018-06-30 | $455k | 14k | 33.70 |
| 2018-03-31 | $896k | 33k | 27.07 |
| 2017-12-31 | $1.3M | 78k | 16.68 |
| 2017-09-30 | $3.2M | 158k | 20.01 |
| 2017-06-30 | $1.6M | 87k | 18.34 |
| 2017-03-31 | $1.0M | 103k | 9.84 |
| 2016-12-31 | $1.4M | 131k | 10.91 |
| 2016-09-30 | $2.5M | 175k | 14.01 |
| 2016-06-30 | $366k | 52k | 7.01 |
| 2016-03-31 | $634k | 99k | 6.44 |
| 2015-12-31 | $3.7M | 114k | 32.40 |
| 2015-09-30 | $4.6M | 174k | 26.70 |
| 2015-06-30 | $433k | 9.0k | 48.11 |
| 2015-03-31 | $858k | 14k | 60.85 |
| 2014-12-31 | $5.0k | 100 | 50.00 |
Top funds holding Ptc Therapeutics
View all funds holding Ptc Therapeutics